The forecasting model projects that without major intervention, 1.8 billion people will have MASLD by 2050, and a ...

Lalan Wilfong, MD, a medical oncologist well-known for his work in practice transformation, said he looks forward to creating "something more or less from scratch." Lalan Wilfong, MD, one of the ...

Projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020 and were driven by new biosimilar entry. Savings were $124.5 billion under an upper-bound ...

Psychological effects of alopecia areata should be looked into in the future for patients who live with the condition.

Equity gaps in lung cancer molecular testing persist; reflex testing and nurse navigation speed care, while coverage and ...

Screening prevalence increased from 31.0% (45-49) to 64.2% (50-64) and 80.9% (65-75), but remained below optimal levels for ...

Telemedicine utilization has declined since the peak of the COVID-19 pandemic, but non–primary care specialties continue to see an increase in moderate- and high-complexity telemedicine visits.

When asked about behavioral support, 56% of employed adults said they would self-pay for a GLP-1 if their employer offered a ...

Advanced disease progression occurred less often with vutrisiran than placebo in both the overall population (8.0% vs 10.7%) ...

Biologic-naïve status and higher inflammation predict rapid skin clearance with psoriasis biologics, while palmoplantar ...

Reflex molecular testing and nurse navigation cut delays in lung cancer care, helping more patients get targeted results ...

ATTAIN demonstrated placebo-adjusted weight reductions of roughly 9–11 percentage points at 72 weeks, with 27.3 lb (12.4%) ...